Impurities in drug substances and drug products: A regulatory CMC perspective
Feature ArticlesYuri Ceragioli, MS
Chemistry, Manufacturing and Controls (CMC)GlobalPharmaceuticalsUnited StatesFeature ArticlesYuri Ceragioli, MSChemistry, Manufacturing and Controls (CMC)GlobalPharmaceuticalsUnited States